(Q46063960)

English

Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

0 references

0 references

0 references

1 reference

ORCID Public Data File 2021

author name string

R K Shenoy

1

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

T K Suma

2

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

V Kumaraswami

3

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

N Rahmah

4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

G Dhananjayan

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

S Padma

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

publication date

1 April 2009

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

number of pages

13

1 reference

based on heuristic

inferred from page(s)

Annals of Tropical Medicine and Parasitology

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

103

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

3

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

235-247

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

Mass treatment to eliminate filariasis in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective.

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

Progression of lymphatic vessel dilatation in the presence of living adult Wuchereria bancrofti

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

The histopathology of bancroftian filariasis revisited: the role of the adult worm in the lymphatic-vessel disease

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

Treatment strategies underpinning the global programme to eliminate lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

Long-term effect of mass diethylcarbamazine chemotherapy on bancroftian filariasis, results at four years after start of treatment.

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

Long-term effect of three different strategies for mass diethylcarbamazine administration in bancroftian filariasis: follow-up at 10 years after treatment

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

Towards a filariasis-free community: evaluation of filariasis control over an eleven year period in Flores, Indonesia

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

Multicentre laboratory evaluation of Brugia Rapid dipstick test for detection of brugian filariasis

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

The efficacy, tolerability and safety of diethylcarbamazine-fortified salt in the treatment of the microfilaraemias of brugian filariasis: an open, hospital-based study.

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in Brugian filariasis

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

Lymphatic filariasis: an infection of childhood

1 reference

https://api.crossref.org/works/10.1179%2F136485909X398249

21 January 2018

Identifiers

10.1179/136485909X398249

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19341538

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46063960&oldid=2089909138"